Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphoma

Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA
Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
Duke University, Durham, NC
Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
Haematologica Early view Jul 2, 2026 https://doi.org/10.3324/haematol.2026.300899

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2026.300899
 
Published
2026-07-02
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
124
PDF Downloads
53
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online